RHEUMATOLOGY INTERNATIONAL is an independent journal reflecting world-wide progress in the research, diagnosis and treatment of the various rheumatic diseases.
It is designed to serve researchers and clinicians in the field of rheumatology.
RHEUMATOLOGY INTERNATIONAL will cover all modern trends in clinical research as well as in the management of rheumatic diseases.
Special emphasis will be given to public health issues related to rheumatic diseases, applying rheumatology research to clinical practice, epidemiology of rheumatic diseases, diagnostic tests for rheumatic diseases, patient reported outcomes (PROs) in rheumatology and evidence on education of rheumatology.
Contributions to these topics will appear in the form of original publications, short communications, editorials, and reviews. "Letters to the editor" will be welcome as an enhancement to discussion.
Basic science research, including in vitro or animal studies, is discouraged to submit, as we will only review studies on humans with an epidemological or clinical perspective.
Case reports without a proper review of the literatura (Case-based Reviews) will not be published.
Every effort will be made to ensure speed of publication while maintaining a high standard of contents and production.
Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki.
It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study.
Details that might disclose the identity of the subjects under study should be omitted.
Abstracting & Indexing
ScopusGoogle ScholarWeb of ScienceMedlineEmbase
Detailed Metrics
Total Docs. (latest)
277
Total Docs. (3 years)
796
Total Refs.
11,753
Total Citations (3 years)
2,573
Citable Docs. (3 years)
766
Citations / Doc. (2 years)
3.31
Ref. / Doc.
42.43
% Female
49.8%
Metrics Visualization
Latest year data vs 3-year cumulative figures
Female: 49.8% |
Male: 50.2%
Citations / Doc. (2yr)3.31
Average
References / Doc.42.43
High refs
Citable / Total Docs (3yr)96.2%
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Rheumatology International?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Rheumatology International has an SJR of 0.907 and is ranked Q2.
What is the SJR and quartile of Rheumatology International?
Rheumatology International has an SJR (SCImago Journal Rank) of 0.907 and its best quartile is Q2.
What is the H-index of Rheumatology International?
The H-index of Rheumatology International is 100, meaning 100 of its articles have each been cited at least 100 times.
Is Rheumatology International indexed in Scopus?
Yes. Rheumatology International is active in Scopus (Scopus Source List, August 2026).